In 2014, the American Academy of Orthopaedic Surgeons (AAOS), in partnership with POSNA, released clinical practice guidelines on detection and management of Developmental Dysplasia of the Hip (DDH). These guidelines emphasized that, despite being the most common pediatric hip condition, there is a paucity of high level evidence and prospective studies in the literature available to guide practitioners. Consequently, substantial gaps in knowledge related to screening, treatment and management of DDH have resulted.
In an effort to address the gaps in evidence, the International Hip Dysplasia Institute (IHDI) began a multicentre prospective study of infants with hips dislocated at rest in 2010. At two year follow-up, early treatment outcomes were effectively analyzed and compared; however, the long-term impact on the patient’s quality of life and functional outcomes remained unknown. Residual acetabular dysplasia and/or the need for further treatment may not become apparent until later in childhood or adolescence. Thus, there is an evident need for comprehensive long-term follow-up in order to identify risk factors and establish appropriate screening protocols and treatment.
Learn more about the IHDR prospective registry